Russia’s announcement that its coronavirus vaccine had greater than 90% efficacy is being met with substantial skepticism, Science magazine reported.
Science reported a review of the new vaccine by the Gamaleya National Center of Epidemiology and Microbiology in Moscow involved just 20 COVID-19 cases — far too few for the claim of 92% efficacy for the “Sputnik V” vaccine to be convincing.
Pfizer and BioNTech analyzed 94 cases to make their efficacy claim, and other vaccine makers plan to wait for at least 50 or more COVID-19 cases to accumulate in a trial to assess a candidate’s worth, Science reported.
Read more at NEWSMAX.
{Matzav.com}
I wonder what President Harris has to say about this. I know that she is very concerned for the American people.
Maybe Covid took away their sense of smell !
Coronovirus infection only affects the ‘sense of taste’.